ARGATROBAN IN 0.9% SODIUM CHLORIDE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 11 USDMF, 6 JDMF, 1 EU WC, 4 KDMF, 7 NDC API, 9 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers, 19 FDA Orange Book, 2 Europe, 1 Canada, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML), INJECTABLE;INJECTION - 50MG/50ML (1MG/ML), INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML), INJECTABLE;INTRAVENOUS - 50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 125MG/125ML (1MG/ML)

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 Rochem International Inc, 2 SPI Pharma, 1 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 2 Actylis, 1 BASF, 1 Finar, 11 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

11 Film Formers & Plasticizers, 7 Parenteral, 4 Fillers, Diluents & Binders, 4 Taste Masking, 4 Coating Systems & Additives, 3 Topical, 3 Solubilizers, 2 Chewable & Orodispersible Aids, 1 Thickeners and Stabilizers, 1 Co-Processed Excipients, 1 Direct Compression, 1 Soft Gelatin, 1 Emulsifying Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 10 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

6 Others

6 Others

$ Xls

Filters

FILTER :

filter Product Reset all filters

3 All

01 3Novastan

01 Brand Name : Novastan

Argatroban

IPPE

Not Confirmed

02 Brand Name : Novastan

Argatroban

IPPE

Not Confirmed

03 Brand Name : Novastan

Argatroban

IPPE

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

ARGATROBAN IN 0.9% SODIUM CHLORIDE

ARGATROBAN IN 0.9% SODIUM CHLORIDE

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers

11 USDMF

6 JDMF

1 EU WC

4 KDMF

7 NDC API

9 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers

19 FDA Orange Book

2 Europe

1 Canada

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML)

INJECTABLE;INJECTION - 50MG/50ML (1MG/ML)

INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML)

INJECTABLE;INTRAVENOUS - 50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INTRAVENOUS - 125MG/125ML (1MG/ML)

RELATED EXCIPIENT COMPANIES

1 Evonik

1 Rochem International Inc

2 SPI Pharma

1 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

2 Kirsch Pharma

2 Actylis

1 BASF

1 Finar

11 Roquette

1 Shijiazhuang Huaxu Pharmaceutical

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

11 Film Formers & Plasticizers

7 Parenteral

4 Fillers, Diluents & Binders

4 Taste Masking

4 Coating Systems & Additives

3 Topical

3 Solubilizers

2 Chewable & Orodispersible Aids

1 Thickeners and Stabilizers

1 Co-Processed Excipients

1 Direct Compression

1 Soft Gelatin

1 Emulsifying Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

10 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Regulatory FDF Prices

3 Annual Reports

MARKET PLACE

2 APIs

PATENTS & EXCLUSIVITIES

2 US Patents

REF. STANDARDS & IMPURITIES

6 Others

Filters

01

Brand Name : Novastan

Brand Name : Novastan

02

Brand Name : Novastan

Brand Name : Novastan

03

Brand Name : Novastan

Brand Name : Novastan

INJECTABLE;INTRAVENOUS - 50MG/50ML (1MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons